The U.S. Food and Drug Administration today approved Osphena (ospemifene) to treat women experiencing moderate to severe dyspareunia (pain during sexual intercourse), a symptom of vulvar and vaginal atrophy due to menopause.
Domega NY International Co., Ltd Issues an Alert on Undeclared Sulfites in Green Day Brand White Melon Seeds
Domega NY International Co., Ltd. at 47-57 Bridgewater Street Brooklyn New York 11222 is recalling GREEN DAY BRAND WHITE MELON SEEDS because they contain undeclared sulfites. People who have severe sensitivity to sulfites run the risk of serious or life-threatening allergic reactions if they consume this product.
Read The Complete Story!
Lion Pavilion Issues Alert on Undeclared Sulfites in Grassplot Ginger Slices
LION PAVILION LTD. of 56-15 58th Street Maspeth, NY 11378 is recalling Grassplot Ginger Slices because it contains undeclared sulfites. Consumers who have severe sensitivity to sulfites run the risk of serious or life-threatening allergic reactions if they consume this product.
FDA approves Stivarga for advanced gastrointestinal stromal tumors
The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and that no longer respond to other FDA-approved treatments for this disease.
Olaax Corp. Issues a Nationwide Voluntary Recall of All Lots of Maxiloss Weight Advanced Softgels Dietary Supplement
Olaax Corp announced today that it is conducting a voluntary nationwide recall of the company’s dietary supplement sold under the brand name MAXILOSS WEIGHT ADVANCED softgels to the user level because they contain undeclared Sibutramine. Olaax Corp. is conducting a voluntary recall after being notified by the US FDA that testing found the MAXILOSS WEIGHT ADVANCED product, to contain Sibutramine.
FDA alerts health care providers of recall of anemia drug Omontys
The U.S. Food and Drug Administration is alerting health care providers and patients of a voluntary nationwide recall of all lots of Omontys Injection by Affymax, Inc., of Palo Alto, Calif., and Takeda Pharmaceuticals Company Limited, of Deerfield, Ill., due to reports of anaphylaxis, a serious and life-threatening allergic reaction. Omontys is used to treat anemia in adult dialysis patients.
Affymax and Takeda Announce a Nationwide Voluntary Recall of All Lots of OMONTYS® (peginesatide) Injection
Affymax, Inc. (Nasdaq: AFFY) and Takeda Pharmaceutical Company Limited (Takeda) today have decided to voluntarily recall all lots of OMONTYS® (peginesatide) Injection to the user level as a result of new postmarketing reports regarding serious hypersensitivity reactions, including anaphylaxis, which can be life-threatening or fatal. The companies have been working actively with the U.S. Food and Drug Administration (FDA) which has indicated its agreement with this decision.
Bruce Foods Corporation Expands Recall to Indiana of Food Club Red Enchilada Sauce Because of Possible Health Risk
Bruce Foods Corporation of New Iberia, LA is recalling mislabeled cans of 10 oz Food Club Red Enchilada Sauce with code GES 462449, Best Before Date: 12/3/2016 that could contain Green Enchilada Sauce instead of Red Enchilada Sauce. Only the Food Club Green Enchilada contains wheat and soy.
Hy-Vee Issues VoluntaryRecall of Certain Dog Food Products
Hy-Vee, Inc. today issued a voluntary recall of certain bags of Hy-Vee dog food due to elevated levels of a chemical contaminant commonly found in corn.
Routine random tests conducted by the Iowa Department of Agriculture indicated higher-than-normal levels of aflatoxin in some samples of Hy-Vee dog food produced at a Kansas City plant operated by Pro-Pet, LLC.
FDA enters into consent decree with Chicago sprout producer due to unsanitary conditions
U Joo Foods, a Chicago sprout grower and processor and the company’s owner and president, Kiyoung Chin have agreed to enter into a consent decree of permanent injunction sought by the Justice Department on behalf of the U.S. Food and Drug Administration.